/PRNewswire/ UNION therapeutics A/S (UNION), a privately-held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and.
In February, the FDA declined to approve the company s new drug application as it was presented and asked the company to submit additional evidence of effectiveness for epidermolysis bullosa (EB).
Healio Psoriatic Disease | Topical steroids have remained a mainstay first-line treatment for psoriasis, but two new drugs in development aim to revolutionize how topical drugs are used in treatment of the disease.“We’ve had a decent amount of minor innovation in psoriasis,” Mark G. Lebwohl, MD, dean for clinical therapeutics and chair emeritus of the Kimberly and Eric J. Waldman Department of Dermatology
Almirall S.A., a global biopharmaceutical company focused on skin health, has hosted a scientific session during the 30th EADV Congress which addressed the need and importance to focus on patient wellbeing in real-life clinical practice.